Ana B.
- Country
- Spain
- Department
- Oncology department
Research Overview
Data & Insights
Has run more than one trial at 0 of 100 partner sites.
Specializations
Advanced Lung Cancer Treatment
The investigator specializes in treating non-small cell lung cancer (NSCLC) with particular expertise in managing advanced and metastatic cases. Their research encompasses various genetic mutations associated with NSCLC, including RET fusion-positive and KRASG12C mutations.
- Metastatic NSCLC Management
- Genetic Mutation-Targeted Therapies
- First-line Treatment Strategies
Their work extends to treating elderly patients and those with compromised performance status.
Targeted Oncology Therapeutics
Focus areas include the development and implementation of targeted therapeutic approaches for lung cancer, particularly involving EGFR mutations. The investigator works with novel combination therapies and comparative treatment strategies.
- EGFR-Mutated Cancer Treatment
- Combination Therapy Approaches
- Immunotherapy Applications
Special attention is given to managing treatment-related reactions and optimizing therapeutic outcomes.
Post-Surgical Cancer Care
The investigator has expertise in adjuvant therapy for surgically treated lung cancer patients. Their work includes managing completely resected NSCLC cases and implementing post-surgical treatment strategies.
- Post-Resection Treatment
- Disease-Free Survival Enhancement
- Stage-Specific Interventions
Research focuses on improving outcomes for patients with various stages of resected lung cancer.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.